|
End-of-day quote
Nasdaq
10/09/2026
|
5-day change | 1st Jan Change | ||
| 14.79 USD | -6.10% |
|
-9.32% | +13.51% |
| 08-20 | Guggenheim Initiates Freenome at Buy With $21 Price Target | MT |
| 08-18 | Freenome Registers Up To 75.2 Million Shares For Sale | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FREENOME, INC. | Bio Diagnostics & Testing | -6.10% | -9.32% | +13.51% | +40.19% | - | 1.59B |  | | |
- Stock Market
- Stocks
- FRNM Stock
- Charts Freenome, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
